Diovan Hct
Product Images NDC 68258-6056

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Diovan Hct (NDC 68258-6056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6056-xx (Ndc 68258 6056 Xx Norvatis)

This is a warning label on a medication distributed by Novartis Corporation. The medication is DIOVAN HCT 80 mg/12.5 mg, which is light orange and ovaloid in shape. It comes in a bottle with XX tablets. The label cautions against use during pregnancy since it can harm fetal development. The medication may cause drowsiness, dizziness, or headache, and users are advised not to discontinue use without a doctor's advice. Additionally, it recommends storing the medication at 77°F and dispensing it from the bottle with the lot # SAMPLE EXP 00-00 and Rx # 27095349.*

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Diovan Hct 01)

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Diovan Hct 02)

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Diovan Hct 03)

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Diovan Hct 04)

FDA Label Image

Valsartan Structural Formula (Diovan Hct 05)

FDA Label Image

Hydrochlorothiazide Structural Formula (Diovan Hct 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.